Sienna Biopharmaceuticals, Inc. (SNNA) symbol metrics page

Sienna Biopharmaceuticals, Inc.. (SNNA) NASDAQ

$0.14 - (-)

Market Cap: $4.20M

As of 12/16/19 12:00 AM EST. Market closed.

Sienna Biopharmaceuticals, Inc.. (SNNA)
NASDAQ

$0.14
- (-)

Market Cap: $4.20M

As of 12/16/19 12:00 AM EST. Market closed.

Add to Portfolio

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by ... read more

COMPANY PROFILE

Sector

Health Technology

Industry

Pharmaceuticals: Major

CEO

Frederick C. Beddingfield

Full Time Employees

CEO Compensation (Base)

$508,000

CEO Compensation (Total)

$2.62M

URL

siennabio.com

Address

30699 Russell Ranch Road, CA, Westlake Village, 91362.

Sector

Health Technology

Industry

Pharmaceuticals: Major

CEO

Frederick C. Beddingfield

Full Time Employees

CEO Compensation (Base)

$508,000

CEO Compensation (Total)

$2.62M

URL

siennabio.com

Address

30699 Russell Ranch Road, CA, Westlake Village, 91362.

PRICE CHART FOR SIENNA BIOPHARMACEUTICALS, INC.

YTD

MAX

From: To:

NEWS

INSIDEARBITRAGE ARTICLES

KEY STATS

Open

Previous Close

$0.14

Days Range

- - -

52 week range

$0.11 - $0.17

Volume

Avg. Volume (30 days)

13,315,740

Market Cap

$4.20M

Dividend Yield

P/E

Shares Outstanding

30,907,500

Open

Previous Close

$0.14

Days Range

- - -

52 week range

$0.11 - $0.17

Volume

Avg. Volume (30 days)

13,315,740

Market Cap

$4.20M

Dividend Yield

P/E

Shares Outstanding

30,907,500

FINANCIAL STATEMENTS FOR SIENNA BIOPHARMACEUTICALS, INC.

Open in:

INSIDER TRANSACTIONS FOR SIENNA BIOPHARMACEUTICALS, INC.

Owner	Relationship	Date	Transaction	Cost	# Shares	Value($)	Total Shares	Form 4
Azoy Alexander	Chief Financial Officer	Oct 02, 2019	Option Exercise	$0.23	2,396	551	103,552	Oct 04, 2019, 02:10 PM
Stroehmann Diane	See Remarks	Jul 02, 2019	Option Exercise	$0.76	4,095	3,112	168,545	Jul 03, 2019, 01:47 PM
Andrews Timothy K.	General Counsel & Secretary	Jul 02, 2019	Option Exercise	$0.76	4,095	3,112	95,558	Jul 03, 2019, 01:42 PM
Lizzul Paul F.	Chief Medical Officer	Jul 02, 2019	Option Exercise	$0.76	4,095	3,112	141,488	Jul 03, 2019, 01:39 PM
Beddingfield III Frederick	President & CEO	Jul 02, 2019	Option Exercise	$0.76	17,063	12,968	817,599	Jul 03, 2019, 01:35 PM
Azoy Alexander	Chief Financial Officer	Jul 02, 2019	Option Exercise	$0.76	1,552	1,180	35,948	Jul 03, 2019, 12:00 AM
ARCH Venture Partners X, LLC	10% Owner	Feb 22, 2019	Buy	$2.50	2,165,800	5,414,500	2,900,575	Feb 26, 2019, 09:08 PM
ARCH Venture Partners VIII, LLC	10% Owner	Feb 22, 2019	Buy	$2.50	2,165,800	5,414,500	2,900,575	Feb 26, 2019, 09:06 PM
Burow Kristina	Director	Feb 22, 2019	Buy	$2.50	2,165,800	5,414,500	2,900,575	Feb 26, 2019, 09:03 PM
MORE ROBERT J	Director	Feb 22, 2019	Buy	$2.50	100,000	250,000	255,942	Feb 26, 2019, 05:16 PM
Leonard Keith R	Director	Feb 22, 2019	Buy	$2.50	100,000	250,000	100,000	Feb 26, 2019, 05:14 PM
Beddingfield III Frederick	President & CEO	Feb 22, 2019	Buy	$2.50	40,000	100,000	831,662	Feb 26, 2019, 05:12 PM
Harris Todd	Head of Corporate Development	Apr 30, 2018	Sale	$20.00	100	2,000	570,991	May 02, 2018, 07:54 PM
Harris Todd	Head of Corporate Development	Apr 23, 2018	Sale	$20.00	525	10,500	571,541	Apr 25, 2018, 07:21 PM
Harris Todd	Head of Corporate Development	Apr 25, 2018	Sale	$20.00	300	6,000	571,091	Apr 25, 2018, 07:21 PM
Harris Todd	Head of Corporate Development	Apr 24, 2018	Sale	$20.00	150	3,000	571,391	Apr 25, 2018, 07:21 PM
Harris Todd	Head of Corporate Development	Apr 18, 2018	Sale	$20.09	15,810	317,599	572,066	Apr 19, 2018, 06:00 PM
Harris Todd	Head of Corporate Development	Apr 17, 2018	Sale	$20.00	2,201	44,020	587,876	Apr 19, 2018, 06:00 PM
Harris Todd	Head of Corporate Development	Apr 10, 2018	Sale	$20.02	3,779	75,641	590,077	Apr 12, 2018, 06:45 PM
Harris Todd	Head of Corporate Development	Apr 09, 2018	Sale	$20.00	2,824	56,480	593,856	Apr 09, 2018, 07:18 PM
Harris Todd	Head of Corporate Development	Apr 05, 2018	Sale	$20.00	5,386	107,725	596,680	Apr 09, 2018, 07:18 PM
MORE ROBERT J	Director	Mar 28, 2018	Sale	$18.84	10,000	188,400	193,249	Mar 29, 2018, 08:50 PM
MORE ROBERT J	Director	Mar 29, 2018	Sale	$18.78	14,429	270,977	178,820	Mar 29, 2018, 08:50 PM
Harris Todd	Head of Corporate Development	Mar 19, 2018	Sale	$20.00	5,876	117,520	602,066	Mar 20, 2018, 07:00 PM
Harris Todd	Head of Corporate Development	Mar 12, 2018	Sale	$20.11	3,452	69,429	607,942	Mar 14, 2018, 07:13 PM
Harris Todd	Head of Corporate Development	Mar 09, 2018	Sale	$20.01	2,438	48,784	611,394	Mar 09, 2018, 07:00 PM
Harris Todd	Head of Corporate Development	Mar 08, 2018	Sale	$20.03	14,530	291,097	613,832	Mar 09, 2018, 07:00 PM
Harris Todd	Head of Corporate Development	Mar 07, 2018	Sale	$20.00	3,704	74,080	628,362	Mar 09, 2018, 07:00 PM
FENTON DENNIS M	Director	Sep 18, 2017	Buy	$22.96	1,250	28,698	1,250	Sep 19, 2017, 11:56 AM
Stroehmann Diane	See Remarks	Aug 01, 2017	Buy	$15.00	7,000	105,000	124,724	Aug 01, 2017, 04:27 PM
PETERSON RICHARD D	Chief Financial Officer	Aug 01, 2017	Buy	$15.00	7,000	105,000	7,000	Aug 01, 2017, 04:26 PM
MAST ERLE T	Director	Aug 01, 2017	Buy	$15.00	6,700	100,500	6,700	Aug 01, 2017, 04:24 PM
Lizzul Paul F.	Chief Medical Officer	Aug 01, 2017	Buy	$15.00	10,000	150,000	94,634	Aug 01, 2017, 04:23 PM
Leonard Keith R	Director	Aug 01, 2017	Buy	$15.00	16,700	250,500	16,700	Aug 01, 2017, 04:22 PM
Andrews Timothy K.	General Counsel & Secretary	Aug 01, 2017	Buy	$15.00	15,000	225,000	15,000	Aug 01, 2017, 04:19 PM

Load More Insider Transactions

Buy Sale Option Exercise

Owner	Relationship	Date	Value($)
Azoy Alexander	Chief Financial Officer	10/02/2019	551
Stroehmann Diane	See Remarks	07/02/2019	3,112
Andrews Timothy K.	General Counsel & Secretary	07/02/2019	3,112
Lizzul Paul F.	Chief Medical Officer	07/02/2019	3,112
Beddingfield III Frederick	President & CEO	07/02/2019	12,968
Azoy Alexander	Chief Financial Officer	07/02/2019	1,180
ARCH Venture Partners X, LLC	10% Owner	02/22/2019	5,414,500
ARCH Venture Partners VIII, LLC	10% Owner	02/22/2019	5,414,500
Burow Kristina	Director	02/22/2019	5,414,500
MORE ROBERT J	Director	02/22/2019	250,000
Leonard Keith R	Director	02/22/2019	250,000
Beddingfield III Frederick	President & CEO	02/22/2019	100,000
Harris Todd	Head of Corporate Development	04/30/2018	2,000
Harris Todd	Head of Corporate Development	04/23/2018	10,500
Harris Todd	Head of Corporate Development	04/25/2018	6,000
Harris Todd	Head of Corporate Development	04/24/2018	3,000
Harris Todd	Head of Corporate Development	04/18/2018	317,599
Harris Todd	Head of Corporate Development	04/17/2018	44,020
Harris Todd	Head of Corporate Development	04/10/2018	75,641
Harris Todd	Head of Corporate Development	04/09/2018	56,480
Harris Todd	Head of Corporate Development	04/05/2018	107,725
MORE ROBERT J	Director	03/28/2018	188,400
MORE ROBERT J	Director	03/29/2018	270,977
Harris Todd	Head of Corporate Development	03/19/2018	117,520
Harris Todd	Head of Corporate Development	03/12/2018	69,429
Harris Todd	Head of Corporate Development	03/09/2018	48,784
Harris Todd	Head of Corporate Development	03/08/2018	291,097
Harris Todd	Head of Corporate Development	03/07/2018	74,080
FENTON DENNIS M	Director	09/18/2017	28,698
Stroehmann Diane	See Remarks	08/01/2017	105,000
PETERSON RICHARD D	Chief Financial Officer	08/01/2017	105,000
MAST ERLE T	Director	08/01/2017	100,500
Lizzul Paul F.	Chief Medical Officer	08/01/2017	150,000
Leonard Keith R	Director	08/01/2017	250,500
Andrews Timothy K.	General Counsel & Secretary	08/01/2017	225,000

Load More Insider Transactions

BUYBACK ANNOUNCEMENT(S) FOR SIENNA BIOPHARMACEUTICALS, INC.

Active Completed

Looking for more premium content?